These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 5651519)
21. The pharmacologic activity of a group of new barbituric acid derivatives. Pelczarska A; Szaga B Arch Immunol Ther Exp (Warsz); 1969; 17(4):547-54. PubMed ID: 5817418 [No Abstract] [Full Text] [Related]
22. Synthesis and pharmacological activity of some 2,3-dihydrofuran-2,3-dione derivatives. Zankowska-Jasińska W; Burgieł M; Golus J; Kolasa A; Walocha K; Zaleska B; Chojnacka-Wójcik E; Wiczyńska B; Tatarczyńska E Pol J Pharmacol Pharm; 1982; 34(5-6):391-8. PubMed ID: 6985305 [TBL] [Abstract][Full Text] [Related]
23. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines. Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacological properties of 1-[2-hydroxy-3-(4-o,m,p-halogenophenyl)- and 3-(4-m-chlorophenyl)-1-piperazinyl]propyl derivatives of amides of 7-methyl-3-phenyl-2,4-dioxo-1,2,3,4-tetrahydropyrido [2,3-d]pyrimidine-5-carboxylic acid with analgesic and sedative activities. Sabiniarz A; Sladowska H; Filipek B; Sapa J; Dudek M; Slepokura K Acta Pol Pharm; 2007; 64(4):369-76. PubMed ID: 18536164 [TBL] [Abstract][Full Text] [Related]
25. Derivatives of 3, 3-spirobi-5-methyltetrahydrofuranone-2 as potential neurotropic agents. Part I. Wagner E; Bobrański B Pol J Pharmacol Pharm; 1976; 28(2):213-6. PubMed ID: 934950 [TBL] [Abstract][Full Text] [Related]
27. Effect of gamma-aminobutyric acid derivatives, especially homopantothenic acid, on the excitability of the brain. Nishizawa Y; Kodama T; Tsujino G J Vitaminol (Kyoto); 1968 Dec; 14(4):331-44. PubMed ID: 5715258 [No Abstract] [Full Text] [Related]
28. Gamma hydroxybutyric acid. Clinical pharmacology and current status. Vickers MD Proc R Soc Med; 1968 Aug; 61(8):821-4. PubMed ID: 5673414 [No Abstract] [Full Text] [Related]
29. [Effect of new pyrazolo-(1,2-a)-1,2,5-triazepine derivatives on the central nervous system]. Szadowska A; Mazur M; Kamińska A; Kusowska J; Winer A Acta Pol Pharm; 1982; 39(5-6):463-67. PubMed ID: 7171016 [No Abstract] [Full Text] [Related]
30. [SUBSTITUTED 4-QUINAZOLINONE DERIVATIVES AS HYPNOTICS AND ANTICONVULSANTS]. BOLTZE KH; DELL HD; LEHWALD H; LORENZ D; RUEBERG-SCHWEER M Arzneimittelforschung; 1963 Aug; 13():688-701. PubMed ID: 14085923 [No Abstract] [Full Text] [Related]
31. [Studies on new hypnotic drugs. Communication 6. Pharmacological properties of new methylallyltetrahydrofuranone derivatives]. GIELDANOWSKI J; WILIMOWSKI M Arch Immunol Ther Exp (Warsz); 1960; 8():361-9. PubMed ID: 13705159 [No Abstract] [Full Text] [Related]
32. Synthesis of derivatives of beta-aminomethyl-gamma-(p-chlorophenyl)-gamma-hydroxybutyric acid. Jakóbiec T; Zabska R; Zawisza T Pol J Pharmacol Pharm; 1982; 34(4):239-46. PubMed ID: 7182845 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and action on the central nervous system of 9,10-dihydropyrrolo [3,4-b][1,4]benzoxazepine derivatives. Budzisz E; Kostka K; Szadowska A; Pakulska W Acta Pol Pharm; 1994; 51(1):45-50. PubMed ID: 7976433 [TBL] [Abstract][Full Text] [Related]
34. The effect of cinnamohydroxamic acid on the central nervous system. Shapero M; Wilson C Br J Pharmacol Chemother; 1966 Jan; 26(1):41-9. PubMed ID: 5919514 [No Abstract] [Full Text] [Related]
35. [Effect of naftidrofuryl on cerebral energy metabolism in mice. 2nd part]. Meynaud A; Grand M; Belleville M; Fontaine L Therapie; 1975; 30(5):777-88. PubMed ID: 1221567 [No Abstract] [Full Text] [Related]
36. Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors. Im HK; Im WB; Hamilton BJ; Carter DB; Vonvoigtlander PF Mol Pharmacol; 1993 Oct; 44(4):866-70. PubMed ID: 7901754 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of the anticonvulsant and central effects of 3-bromophenylsuccinimide and N-methylimide of 3,5-dibromophenylsuccinic acid]. Kleinrok Z; Sieklucka-Dziuba M; Chodkowska A Acta Pol Pharm; 1982; 39(5-6):475-82. PubMed ID: 6927301 [No Abstract] [Full Text] [Related]
38. Synthesis and chromatographic properties of 1,3-thiazane-2-carboxylic acid (beta-homothiaproline). Foppoli C; Cini C; Blarzino C; De Marco C Ital J Biochem; 1980; 29(4):251-9. PubMed ID: 7216718 [TBL] [Abstract][Full Text] [Related]
39. Influence of new gamma-aminobutyric acid amide derivatives and its phthalimide precursors on the central nervous system activity in mice. Mendyk A; Sałat K; Librowski T; Czarneck R; Malawska B Pol J Pharmacol; 2001; 53(6):689-93. PubMed ID: 11985348 [TBL] [Abstract][Full Text] [Related]
40. [Methods of pharmacological control of neurosmuscular syndromes of tetanus. Mechanism of action of anticonvulsants and sedatives]. Gomes FP Rev Bras Anestesiol; 1969; 19(3):327-34. PubMed ID: 5376927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]